# 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients

> **NCT02334722** · PHASE4 · COMPLETED · sponsor: **University of Florida** · enrollment: 81 (actual)

## Conditions studied

- Brain Neoplasms
- Brain Cancer
- Brain Tumors
- Cancer of the Brain
- Cancer of Brain
- Seizure

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT02334722
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-05
- **Primary completion:** 2020-10-07
- **Final completion:** 2020-10-07
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2021-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02334722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02334722, "1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02334722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*